Webinar: Canadian Cancer Society Breakthrough Team Grants
The Canadian Cancer Society and the Canadian Institutes of Health Research – Institute of Cancer Research (ICR) have launched a new funding opportunity. The intent of the CCS Breakthrough Team Grants: Transforming Low Survival Cancers is to bring together the sharpest minds and research talent from across Canada and beyond. By combining scientific, clinical, and patient expertise, in a collaborative, interdisciplinary environment and integrating the power of new technologies and interventions, the hope is to find new ways to prevent the onset of, improve survival through early detection when the disease is at its most treatable, including the early detection of recurrence and metastatic spread, and develop more precise and effective treatments with fewer harmful side effects for the following six cancers:
- pancreas
- esophagus
- brain
- lung
- liver
- stomach
Funds available :
- Up to $45M total over 5 years for this funding program
- Up to $7.5M per team over 5 years
Please note there is a mandatory Expression of Interest (EOI) Phase; you must complete an Expression of Interest by June 22, 2022. There is also a mandatory EOI Webinar to attend June 28, 2022, 1 - 5pm AST.
Click here for more information. More announcements about subsequent application phases will be made available when CCS releases details.
ORS contact: susan.haydt@dal.ca
CCS Contact: research@cancer.ca
Time